Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IKEA Switzerland see sustainability as an opportunity to lead

IKEA Retail Switzerland believe sustainability is an opportunity for IKEA to take the lead in the country, even though it comes with a big responsibility.In July 2019, Ingka Group announced that the Country Retail Managers of the IKEA retail businesses will take on the role of Chief Sustainability Officer (CSO) . Through the integrated role, those managers take greater leadership in moving towards the IKEA ambition to inspire and enable one billion people to live a better life

Read original

Start of bridging pharmacokinetic and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator O304

Betagenon /Balticgruppen Bio AB announces the start of a bridging PK and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator compound O304.In previous Phase I and Phase IIa clinical trials in healthy subjects and in type 2 diabetics, the small molecule AMPK activator compound O304 was administered as a suspension and with limited oral bioavailability. A novel formulation of O304 has now been developed that unexpectedly improved oral bioavailability markedly in animals. A patent application (matter of composition) with priority date to 2039 without extensions

Norwegian Energy Company ASA: Invitation to presentation of Noreco's second quarter 2020 results, Friday 21 August

Norwegian Energy Company ASA (“Noreco” or “the Company”) will publish its second quarter results for 2020 on Friday 21 August 2020, at 07:00 AM CEST. The quarterly report and presentation will be made available on the Company's website www.noreco.com. Executive Chair, Riulf Rustad, Chief Executive Officer, David B. Cook, Chief Financial Officer, Euan Shirlaw and Chief Operating Officer, Atle Sonesen will present the quarterly results in a webcast followed by a Q&A session at 2:30pm CEST. To join webcast: https://channel.royalcast.com/webcast/hegnarmedia/20200821_1/Contact:

S.M. Group launches Denimmune fabrics, treated with Polygiene ViralOff®

The Pakistan-based manufacturer of denim presented the new textile product at Denim Expo recently. The production is already rolling and the order value for Polygiene is estimated at 5 MSEK annually. As consumers we tend not to see them, but S.M. group is one of the “unseen heroes” in the fashion industry, the textile makers who manufacture for the well known consumer brands.  S.M. has during the years created many innovative denim ranges like DNA, Denovation and Feather Lite, but this is the first antimicrobial protection range.  "It’s the need of the time, we have foreseen

Unique concept for the production of flame-retardant wood

ALL-IN-ONE by Woodsafe offers a unique package of expertise where all parts of the flame-retardant wood production chain are gathered under one roof. "With our partner, we take control of the entire process. We guarantee our clients exactly the quality they want," says Thomas Bengtsson, CEO of Woodsafe.As a purchaser of flame-retardant wood, it can be difficult to gain an overview of the entire value chain, as it often involves different suppliers, sometimes in several countries. Woodsafe is now launching ALL-IN-ONE by Woodsafe, a quality-assured production chain where only one player

Postal voting EQL Pharma AGM 2020

EQL Pharma AB (publ), 556713-3425, Annual General Meeting will take place on Thursday, August 27th, 2020 at. 4 PM at EQL Pharma AB's offices, Stortorget 1 Lund.According to the Act (2020: 198) on temporary exemptions to facilitate the conduct of general and association meetings, the Board of Directors of EQL Pharma AB (corporate identity number 556713-3425) (“EQL Pharma”) has decided that shareholders shall be able to exercise their voting rights before the Annual General Meeting per mail. If shareholders wish to exercise their voting rights by postal vote before the Annual General

Finnfund provides US$10 million loan to First National Bank Ghana to strengthen capacity in Ghanaian financial sector

Press release 17 August 2020Finnfund, a Finnish development finance company and impact investor, has provided a US$ 10 million senior loan to First National Bank Ghana Ltd. One of the key objectives of Finnfund’s investment is to support the Ghanaian financial sector and the growth of small and medium-sized enterprises (SMEs), and in particular, foster affordable housing in the country. According to estimations, Ghana is facing a shortage of approximately 2 million homes against a population of 30 million. First National Bank Ghana (FNB Ghana) 

Fellow Finance expands Management Team

FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 17.8.2020 AT 11:10 AMJuha Saari has been appointed as Director of Consumer Finance and will also become a member of the company Management Team. Miikka Silvonen has been appointed as Director of Business Finance and as a member of Management Team. Simultaneously current Management Team member Antoni Airikkala has been appointed as Director responsible for investor clients. Juha Saari joined Fellow Finance in July 2020 and has been working in the field of consumer finance for the past 12 years. He has previously served as the COO and Head of

The Board of Directors decides to call an Extraordinary General Meeting

The Board of Directors has decided to call an Extraordinary General Meeting on September 30 in order to propose a dividend for the 2019 financial year of SEK 0.50 per share. Notice to attend the meeting will be issued at a later date.At the Annual General Meeting on April 28, a decision was taken to not issue any dividend for the 2019 financial year. The Board wanted to wait until the consequences of the Covid-19 pandemic could be better assessed and if circumstances allowed, to call an Extraordinary General Meeting during the second half of 2020. The consequences of the pandemic can now

Lesjöfors takes new steps into the space sector

In July 2020, the US company Purdy Engineering contacted John While Solutions in Singapore to develop and manufacture volute springs for a space vessel. The smooth spring development process resulted in a satisfied customer and high-performance springs in space.Transforming industry The American space industry is still very active, but is transforming from government sponsorship to being entrepreneurially driven. One of the most well-known space projects is Falcon 9 that in June took two astronauts to the International Space Station ISS. It was the first rocket ever designed and

NetEnt launches live casino in Lithuania with Betsafe

Following a series of portfolio enhancements, the supplier’s live casino games are now available to players In Lithuania for the first time.NetEnt has made its debut in Lithuania following a successful integration of its live casino games with Betsson Group’s Betsafe brand, strengthening the supplier’s stronghold in regulated European markets. NetEnt Live’s portfolio has recently undergone a major revamp with a series of enhancements to the player experience, including upgrades to the user interface and navigation to make for a more intuitive design. It has also bolstered its offering

Valor Global FX Fund reports a new deposit of capital

Valor Global FX, FX International AB (publ.) fund in Malta reports that it has received a new deposit to the fund of approximately 1,000,000 SEK from an external investor.Valor Global FX has received capital from a new external professional investor totaling 100,000EURO (about 1MSEK). The money has been verified and is now undergoing the usual examination and will then be added to the total capital of the fund. As previously announced, FX International AB (publ.) invested a total of SEK 20 million in May 2020 to get the fund up and running and to obtain actual data from trading. As

SMART-TRIAL uplifting study safety reporting for MedTech

New SMART-TRIAL Adverse Event reporting capabilities helps medical device companies comply with international standards and regulations on safety reporting in clinical studiesAalborg, August 17, 2020 SMART-TRIAL has deployed a new global release of its software to enable MedTech clinical teams to comply with international standards on Adverse Event (AE) Reporting, such as the  ISO14155 and the Medical Device Regulation. This move is the first by any Electronic Data Capture vendor to provide in-built functionality directly tackling  compliance requirements set forth by regulations and

Save the date – Episurf Medical capital markets day 2020

Episurf Medical (Nasdaq: EPIS B) invites investors, analysts and media to a digital capital markets day on Tuesday 15 September 2020. Presentations will be held by members of Episurf Medical’s management group and key customers with the objective to increase the understanding of Episurf Medical’s business, technology, results and future opportunities. The digital capital markets day on 15 September starts at 13:00 CEST and ends at 16:00 CEST. The complete programme and link to the event will be made available on www.episurf.com before the event. A webcast of the event will also be

Stefan Nilsson, CEO of Lumito, has passed away

"It is with great sadness that we announce this tragic and highly unexpected message," says Masoud Khayyami, Chairman of the Board of Lumito. “Stefan Nilsson has left us very unexpectedly. He passed away yesterday due to a heart attack, in connection with exercise on Friday. Our thoughts go to Stefan's family and loved ones.” “With his solid experience from the HighTech and the MedTech industry and through his strong and genuine commitment, Stefan has been an exceptionally strong and skilled leader for Lumito which he in our eyes, has led to become a very promising MedTech company. We

BEWiSynbra Group interim report for the period January to June 2020

HIGHLIGHTS for the second quarter of 2020 Numbers in parentheses refers to the corresponding periods in the previous year · BEWiSynbra Group reported net sales of 1,120 million for the second quarter(SEK 1,222 million), a decrease of 8.3 per cent compared to the corresponding quarter last year · Adjusted EBITDA was SEK 168 million (SEK 171 million), while adjusted EBITA amounted to SEK 111 million (SEK 116 million) · EBIT for the Group was SEK 127 million (SEK 95 million) · Net profit was SEK 91 million (SEK 43 million) · Stable result with adj. EBITDA in line with

TORM plc Second Quarter and Half-Year Report 2020

“The strong market during the first quarter continued into the second quarter of 2020, which has resulted in the strongest half-year since 2008. TORM achieved a profit before tax of USD 128m for the first six months of 2020. I am pleased that TORM’s strong financial position allows us to distribute a total of USD 63m, or DKK 397m, in dividends to our shareholders for the half-year. With recent sales of seven older vessels at attractive prices, we have continued our ongoing fleet renewal activities, enabling TORM to actively pursue attractive opportunities in the market as they arise,” says

INTERIM REPORT Period from January 2020 to June 2020 Lune Group OY incl subsidiary is consolidated in the group from 2020-06-03

Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED) Group, Lune Group OY incl subsidiary is included from 2020-06-03 2020 SECOND QUARTER (Apr-Jun) · Net sales of products KSEK 3 572 (1 011) · Gross profit KSEK 2 417 (768), Gross margin 68% (76%) · Operating loss KSEK -7 166 (-5 797)  · Loss per share SEK -0.05 (-0.06) 2020 FIRST HALF YEAR (Jan-Jun) · Net sales of products KSEK 5 353 (2 481) · Gross profit KSEK 3 402 (1 570), Gross margin 64% (63%) · Operating loss KSEK -12 973 (-9 695)  · Loss per share SEK -0.08 (-0.11)

The results of Enzymatica's placebo-controlled, randomized study show statistically significant shorter common colds and good treatment efficacy when using ColdZyme

The final results of Enzymatica's double-blind, randomized, placebo-controlled study in Germany provide additional clinical evidence for the use of ColdZyme® in the common cold. The results show a statistically significant favourable efficacy for the participants treated with ColdZyme compared to the placebo group. Several study parameters also show statistically significant differences or trends in favour of ColdZyme, mainly regarding shorter common colds compared to placebo. In addition, the study results confirmed the excellent safety data for the product from previous studies, but now in

Speed Group secures logistics contract

Speed Group has been entrusted by an existing customer to expand operations in a business including traditional storage services as well as production-focused assembly and configuration services. The four-year contract is expected to generate additional sales of approximately SEK 100m per year and will commence in 2021.“We are delighted to win new contracts in these times and to be given the opportunity to substantially increase our business with one of our most important customers. This is a result of long-term development efforts, in which our team proactively presented solutions that

CTT puts the A320 OEM-project on hold as Airbus discontinues DAGS Moisture Control System development for Airbus A321XLR

CTT SYSTEMS AB (“CTT”), the market leader of aircraft humidity control systems, puts its development of the Anti-Fuselage-Condensation system for line-fit on the Airbus A320 Family on hold. CTT was notified by Airbus that the DAGS (Dry Air Generation System) Moisture Control System has been removed from the options baseline on the A321XLR aircraft. This follows Airbus’ recent decision to opt only for passive means for condensation reduction for this aircraft type. CTT regrets the decision and engages to obtain that Airbus remains committed and resumes DAGS development, while reserving its

Sectra signs enterprise imaging contract with academic health system in the US

Linköping, Sweden and Shelton, CT – August 17, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) will install its enterprise imaging solution throughout Michigan Medicine. This unified imaging strategy will support work-sharing, subspecialty interpretation of studies acquired at any location within the system, and remote reading.The contract, signed in July, comprises modules for radiology and orthopaedics as well as a VNA with the ability to store all departmental imaging. The solution, deeply integrated with Epic Radiant, will

ASSA ABLOY acquires Access-IS in the UK

ASSA ABLOY has acquired Access-IS, a leading provider of electronic RFID, NFC and barcode devices enabling the authentication of travel and identity documents, ticket reading and contactless payments. "I am very pleased to welcome Access-IS and their employees into the ASSA ABLOY Group. Access-IS is a strategic technological addition to the ASSA ABLOY Group. The company will reinforce our current offering within extended access technologies and will provide complementary growth opportunities,” says Nico Delvaux, President and CEO of ASSA ABLOY. “Access-IS solutions are a good fit for

There are no items matching the current filter
There are no more items matching the current filter
Back to top